25 XP   0   0   10

Firebrick Pharma Ltd
Buy, Hold or Sell?

Let's analyse Firebrick Pharma Ltd together

PenkeI guess you are interested in Firebrick Pharma Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Firebrick Pharma Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Firebrick Pharma Ltd

I send you an email if I find something interesting about Firebrick Pharma Ltd.

Quick analysis of Firebrick Pharma Ltd (30 sec.)










What can you expect buying and holding a share of Firebrick Pharma Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$-0.12
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.13
Return On Investment
-168.5%

For what price can you sell your share?

Current Price per Share
A$0.08
Expected price per share
A$0.058 - A$0.15
How sure are you?
50%

1. Valuation of Firebrick Pharma Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.08

Intrinsic Value Per Share

A$-0.49 - A$-0.59

Total Value Per Share

A$-0.48 - A$-0.58

2. Growth of Firebrick Pharma Ltd (5 min.)




Is Firebrick Pharma Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5m$5.3m-$3.7m-234.4%

How much money is Firebrick Pharma Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$4.3m-$2.4m-$1.9m-44.2%
Net Profit Margin-819,526.7%-92,054.1%--

How much money comes from the company's main activities?

3. Financial Health of Firebrick Pharma Ltd (5 min.)




What can you expect buying and holding a share of Firebrick Pharma Ltd? (5 min.)

Welcome investor! Firebrick Pharma Ltd's management wants to use your money to grow the business. In return you get a share of Firebrick Pharma Ltd.

What can you expect buying and holding a share of Firebrick Pharma Ltd?

First you should know what it really means to hold a share of Firebrick Pharma Ltd. And how you can make/lose money.

Speculation

The Price per Share of Firebrick Pharma Ltd is A$0.077. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Firebrick Pharma Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Firebrick Pharma Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Firebrick Pharma Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-31.7%-0.02-31.7%-0.01-17.7%-0.01-14.2%-0.01-14.2%
Usd Book Value Change Per Share-0.02-27.0%-0.02-27.0%-0.01-15.3%0.002.3%0.002.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-27.0%-0.02-27.0%-0.01-15.3%0.002.3%0.002.3%
Usd Price Per Share0.10-0.10-0.17-0.05-0.05-
Price to Earnings Ratio-4.08--4.08--12.49--3.31--3.31-
Price-to-Total Gains Ratio-4.78--4.78--14.48--9.63--9.63-
Price to Book Ratio11.20-11.20-5.73-3.39-3.39-
Price-to-Total Gains Ratio-4.78--4.78--14.48--9.63--9.63-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0494417
Number of shares20225
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.020.00
Gains per Quarter (20225 shares)-421.1635.94
Gains per Year (20225 shares)-1,684.62143.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1685-16950144134
20-3369-33800288278
30-5054-50650431422
40-6738-67500575566
50-8423-84350719710
60-10108-101200863854
70-11792-1180501006998
80-13477-13490011501142
90-15162-15175012941286
100-16846-16860014381430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.03.00.040.0%2.03.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.05.00.0%0.00.05.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.03.00.040.0%2.03.00.040.0%

Fundamentals of Firebrick Pharma Ltd

About Firebrick Pharma Ltd

Firebrick Pharma Limited engages in the development and partnering of broad-spectrum antimicrobial spray for the treatment of common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-04-19 22:18:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Firebrick Pharma Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Firebrick Pharma Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of -819,526.7% means that $-8,195.27 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Firebrick Pharma Ltd:

  • The MRQ is -819,526.7%. The company is making a huge loss. -2
  • The TTM is -819,526.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-819,526.7%TTM-819,526.7%0.0%
TTM-819,526.7%YOY-92,054.1%-727,472.7%
TTM-819,526.7%5Y-182,490.6%-637,036.1%
5Y-182,490.6%10Y-182,490.6%0.0%
1.1.2. Return on Assets

Shows how efficient Firebrick Pharma Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • -228.1% Return on Assets means that Firebrick Pharma Ltd generated $-2.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Firebrick Pharma Ltd:

  • The MRQ is -228.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -228.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-228.1%TTM-228.1%0.0%
TTM-228.1%YOY-43.5%-184.6%
TTM-228.1%5Y-116.6%-111.5%
5Y-116.6%10Y-116.6%0.0%
1.1.3. Return on Equity

Shows how efficient Firebrick Pharma Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • -274.7% Return on Equity means Firebrick Pharma Ltd generated $-2.75 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Firebrick Pharma Ltd:

  • The MRQ is -274.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -274.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-274.7%TTM-274.7%0.0%
TTM-274.7%YOY-45.9%-228.9%
TTM-274.7%5Y-158.5%-116.2%
5Y-158.5%10Y-158.5%0.0%

1.2. Operating Efficiency of Firebrick Pharma Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Firebrick Pharma Ltd is operating .

  • Measures how much profit Firebrick Pharma Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of -826,956.5% means the company generated $-8,269.57  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Firebrick Pharma Ltd:

  • The MRQ is -826,956.5%. The company is operating very inefficient. -2
  • The TTM is -826,956.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-826,956.5%TTM-826,956.5%0.0%
TTM-826,956.5%YOY-91,953.6%-735,002.9%
TTM-826,956.5%5Y-183,996.6%-642,960.0%
5Y-183,996.6%10Y-183,996.6%0.0%
1.2.2. Operating Ratio

Measures how efficient Firebrick Pharma Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 8,259.10 means that the operating costs are $8,259.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 8,259.095. The company is inefficient in keeping operating costs low. -1
  • The TTM is 8,259.095. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ8,259.095TTM8,259.0950.000
TTM8,259.095YOY1,182.540+7,076.555
TTM8,259.0955Y1,890.472+6,368.623
5Y1,890.47210Y1,890.4720.000

1.3. Liquidity of Firebrick Pharma Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Firebrick Pharma Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 5.11 means the company has $5.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 5.113. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.113. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.113TTM5.1130.000
TTM5.113YOY18.503-13.391
TTM5.1135Y21.661-16.548
5Y21.66110Y21.6610.000
1.3.2. Quick Ratio

Measures if Firebrick Pharma Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 4.92 means the company can pay off $4.92 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 4.921. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.921. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.921TTM4.9210.000
TTM4.921YOY18.273-13.352
TTM4.9215Y19.057-14.137
5Y19.05710Y19.0570.000

1.4. Solvency of Firebrick Pharma Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Firebrick Pharma Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Firebrick Pharma Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.17 means that Firebrick Pharma Ltd assets are financed with 17.0% credit (debt) and the remaining percentage (100% - 17.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 0.170. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.170. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.170TTM0.1700.000
TTM0.170YOY0.052+0.118
TTM0.1705Y0.145+0.025
5Y0.14510Y0.1450.000
1.4.2. Debt to Equity Ratio

Measures if Firebrick Pharma Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 20.5% means that company has $0.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Firebrick Pharma Ltd:

  • The MRQ is 0.205. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.205. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.205TTM0.2050.000
TTM0.205YOY0.054+0.150
TTM0.2055Y0.209-0.004
5Y0.20910Y0.2090.000

2. Market Valuation of Firebrick Pharma Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Firebrick Pharma Ltd generates.

  • Above 15 is considered overpriced but always compare Firebrick Pharma Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of -4.08 means the investor is paying $-4.08 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Firebrick Pharma Ltd:

  • The EOD is -2.026. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.078. Based on the earnings, the company is expensive. -2
  • The TTM is -4.078. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.026MRQ-4.078+2.052
MRQ-4.078TTM-4.0780.000
TTM-4.078YOY-12.491+8.414
TTM-4.0785Y-3.314-0.764
5Y-3.31410Y-3.3140.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Firebrick Pharma Ltd:

  • The EOD is -2.382. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.795. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.795. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.382MRQ-4.795+2.413
MRQ-4.795TTM-4.7950.000
TTM-4.795YOY-11.198+6.403
TTM-4.7955Y-3.199-1.596
5Y-3.19910Y-3.1990.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Firebrick Pharma Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 11.20 means the investor is paying $11.20 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Firebrick Pharma Ltd:

  • The EOD is 5.565. Based on the equity, the company is overpriced. -1
  • The MRQ is 11.202. Based on the equity, the company is expensive. -2
  • The TTM is 11.202. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.565MRQ11.202-5.637
MRQ11.202TTM11.2020.000
TTM11.202YOY5.728+5.475
TTM11.2025Y3.386+7.816
5Y3.38610Y3.3860.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Firebrick Pharma Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.032-0.0320%-0.018-44%0.003-1272%0.003-1272%
Book Value Per Share--0.0140.0140%0.046-70%0.027-48%0.027-48%
Current Ratio--5.1135.1130%18.503-72%21.661-76%21.661-76%
Debt To Asset Ratio--0.1700.1700%0.052+229%0.145+17%0.145+17%
Debt To Equity Ratio--0.2050.2050%0.054+276%0.209-2%0.209-2%
Dividend Per Share----0%-0%-0%-0%
Eps---0.038-0.0380%-0.021-44%-0.017-55%-0.017-55%
Free Cash Flow Per Share---0.032-0.0320%-0.024-27%-0.016-52%-0.016-52%
Free Cash Flow To Equity Per Share---0.027-0.0270%0.033-180%0.002-1314%0.002-1314%
Gross Profit Margin--1.0541.0540%1.086-3%1.050+0%1.050+0%
Intrinsic Value_10Y_max---0.591--------
Intrinsic Value_10Y_min---0.495--------
Intrinsic Value_1Y_max---0.030--------
Intrinsic Value_1Y_min---0.029--------
Intrinsic Value_3Y_max---0.113--------
Intrinsic Value_3Y_min---0.106--------
Intrinsic Value_5Y_max---0.223--------
Intrinsic Value_5Y_min---0.203--------
Market Cap13778919.616-101%27736786.24027736786.2400%47420957.120-42%15031548.672+85%15031548.672+85%
Net Profit Margin---8195.267-8195.2670%-920.541-89%-1824.906-78%-1824.906-78%
Operating Margin---8269.565-8269.5650%-919.536-89%-1839.966-78%-1839.966-78%
Operating Ratio--8259.0958259.0950%1182.540+598%1890.472+337%1890.472+337%
Pb Ratio5.565-101%11.20211.2020%5.728+96%3.386+231%3.386+231%
Pe Ratio-2.026+50%-4.078-4.0780%-12.491+206%-3.314-19%-3.314-19%
Price Per Share0.077-101%0.1550.1550%0.265-42%0.084+85%0.084+85%
Price To Free Cash Flow Ratio-2.382+50%-4.795-4.7950%-11.198+134%-3.199-33%-3.199-33%
Price To Total Gains Ratio-2.374+50%-4.779-4.7790%-14.484+203%-9.632+102%-9.632+102%
Quick Ratio--4.9214.9210%18.273-73%19.057-74%19.057-74%
Return On Assets---2.281-2.2810%-0.435-81%-1.166-49%-1.166-49%
Return On Equity---2.747-2.7470%-0.459-83%-1.585-42%-1.585-42%
Total Gains Per Share---0.032-0.0320%-0.018-44%0.003-1272%0.003-1272%
Usd Book Value--1589849.8741589849.8740%5316158.435-70%3053593.234-48%3053593.234-48%
Usd Book Value Change Per Share---0.021-0.0210%-0.012-44%0.002-1272%0.002-1272%
Usd Book Value Per Share--0.0090.0090%0.030-70%0.017-48%0.017-48%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.024-0.0240%-0.014-44%-0.011-55%-0.011-55%
Usd Free Cash Flow---3714530.521-3714530.5210%-2719146.459-27%-1800627.032-52%-1800627.032-52%
Usd Free Cash Flow Per Share---0.021-0.0210%-0.015-27%-0.010-52%-0.010-52%
Usd Free Cash Flow To Equity Per Share---0.017-0.0170%0.021-180%0.001-1314%0.001-1314%
Usd Market Cap8847444.285-101%17809790.44517809790.4450%30448996.567-42%9651757.402+85%9651757.402+85%
Usd Price Per Share0.049-101%0.1000.1000%0.170-42%0.054+85%0.054+85%
Usd Profit---4367610.431-4367610.4310%-2437610.651-44%-1959838.424-55%-1959838.424-55%
Usd Revenue--532.943532.9430%2648.020-80%120192.259-100%120192.259-100%
Usd Total Gains Per Share---0.021-0.0210%-0.012-44%0.002-1272%0.002-1272%
 EOD+3 -5MRQTTM+0 -0YOY+2 -325Y+8 -2610Y+8 -26

3.2. Fundamental Score

Let's check the fundamental score of Firebrick Pharma Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.026
Price to Book Ratio (EOD)Between0-15.565
Net Profit Margin (MRQ)Greater than0-8,195.267
Operating Margin (MRQ)Greater than0-8,269.565
Quick Ratio (MRQ)Greater than14.921
Current Ratio (MRQ)Greater than15.113
Debt to Asset Ratio (MRQ)Less than10.170
Debt to Equity Ratio (MRQ)Less than10.205
Return on Equity (MRQ)Greater than0.15-2.747
Return on Assets (MRQ)Greater than0.05-2.281
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Firebrick Pharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.084
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets2,982
Total Liabilities506
Total Stockholder Equity2,476
 As reported
Total Liabilities 506
Total Stockholder Equity+ 2,476
Total Assets = 2,982

Assets

Total Assets2,982
Total Current Assets2,589
Long-term Assets393
Total Current Assets
Cash And Cash Equivalents 2,355
Net Receivables 137
Other Current Assets 97
Total Current Assets  (as reported)2,589
Total Current Assets  (calculated)2,589
+/-0
Long-term Assets
Property Plant Equipment 34
Long-term Assets Other 359
Long-term Assets  (as reported)393
Long-term Assets  (calculated)393
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities506
Long-term Liabilities0
Total Stockholder Equity2,476
Total Current Liabilities
Accounts payable 197
Other Current Liabilities 309
Total Current Liabilities  (as reported)506
Total Current Liabilities  (calculated)506
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock17,068
Retained Earnings -15,579
Other Stockholders Equity 987
Total Stockholder Equity (as reported)2,476
Total Stockholder Equity (calculated)2,476
+/-0
Other
Capital Stock17,068
Cash and Short Term Investments 2,355
Common Stock Shares Outstanding 170,092
Liabilities and Stockholders Equity 2,982
Net Debt -2,355
Net Invested Capital 2,476
Net Tangible Assets 2,476
Net Working Capital 2,083
Property Plant and Equipment Gross 34



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-30
> Total Assets 
1,176
655
11,768
8,729
2,982
2,9828,72911,7686551,176
   > Total Current Assets 
1,176
654
11,676
8,328
2,589
2,5898,32811,6766541,176
       Cash And Cash Equivalents 
577
93
10,876
7,143
2,355
2,3557,14310,87693577
       Short-term Investments 
0
0
283
0
0
0028300
       Net Receivables 
0
561
503
1,082
137
1371,0825035610
       Other Current Assets 
0
1
14
5
97
9751410
   > Long-term Assets 
0
1
92
401
393
3934019210
       Property Plant Equipment 
1
1
16
42
34
34421611
       Other Assets 
0
0
76
359
0
03597600
> Total Liabilities 
98
264
215
450
506
50645021526498
   > Total Current Liabilities 
43
210
215
450
506
50645021521043
       Accounts payable 
0
204
139
36
197
197361392040
       Other Current Liabilities 
0
6
76
414
309
3094147660
   > Long-term Liabilities 
0
54
0
0
0
000540
> Total Stockholder Equity
1,079
391
11,553
8,279
2,476
2,4768,27911,5533911,079
   Common Stock
2,085
2,655
15,987
16,000
17,068
17,06816,00015,9872,6552,085
   Retained Earnings -15,579-8,805-5,239-2,595-1,006
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 
0
330
806
1,085
987
9871,0858063300



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue1
Cost of Revenue-0
Gross Profit11
 
Operating Income (+$)
Gross Profit1
Operating Expense-6,855
Operating Income-6,864-6,854
 
Operating Expense (+$)
Research Development4,091
Selling General Administrative292
Selling And Marketing Expenses368
Operating Expense6,8554,751
 
Net Interest Income (+$)
Interest Income40
Interest Expense-0
Other Finance Cost-0
Net Interest Income40
 
Pretax Income (+$)
Operating Income-6,864
Net Interest Income40
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,824-6,904
EBIT - interestExpense = -6,864
-6,824
-6,802
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-6,864-6,824
Earnings Before Interest and Taxes (EBITDA)-6,854
 
After tax Income (+$)
Income Before Tax-6,824
Tax Provision-0
Net Income From Continuing Ops-6,802-6,824
Net Income-6,802
Net Income Applicable To Common Shares-6,802
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,865
Total Other Income/Expenses Net40-40
 

Technical Analysis of Firebrick Pharma Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Firebrick Pharma Ltd. The general trend of Firebrick Pharma Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Firebrick Pharma Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Firebrick Pharma Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.105 < 0.14 < 0.15.

The bearish price targets are: 0.058 > 0.058 > 0.058.

Tweet this
Firebrick Pharma Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Firebrick Pharma Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Firebrick Pharma Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Moving Average Convergence/Divergence (MACD) ChartFirebrick Pharma Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Firebrick Pharma Ltd. The current adx is .

Firebrick Pharma Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Relative Strength Index (RSI) ChartFirebrick Pharma Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Stochastic Oscillator ChartFirebrick Pharma Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Commodity Channel Index (CCI) ChartFirebrick Pharma Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Chande Momentum Oscillator (CMO) ChartFirebrick Pharma Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Williams %R ChartFirebrick Pharma Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Average True Range (ATR) ChartFirebrick Pharma Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily On-Balance Volume (OBV) ChartFirebrick Pharma Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Firebrick Pharma Ltd.

Firebrick Pharma Ltd Daily Money Flow Index (MFI) ChartFirebrick Pharma Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Firebrick Pharma Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Firebrick Pharma Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Firebrick Pharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.084
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Firebrick Pharma Ltd with someone you think should read this too:
  • Are you bullish or bearish on Firebrick Pharma Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Firebrick Pharma Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Firebrick Pharma Ltd

I send you an email if I find something interesting about Firebrick Pharma Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Firebrick Pharma Ltd.

Receive notifications about Firebrick Pharma Ltd in your mailbox!